Crinetics Pharmaceuticals, Inc. Increase (Decrease) in Contract with Customer, Liability
Crinetics Pharmaceuticals, Inc. (CRNX) reported Increase (Decrease) in Contract with Customer, Liability of $88.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $516.00K.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$428.00K.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$707.00K.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$144.00K.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$1.83M, a 2579.73% decline from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was $74.00K.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$1.53M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $88.00K 10-Q · filed 2026-08-03 | -$619.00K derived: sum of 3 quarters · filed 2026-08-03 | -$763.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$428.00K 10-Q · filed 2026-05-07 | -$1.14M derived: sum of 2 quarters · filed 2026-05-07 | -$1.28M derived: sum of 3 quarters · filed 2026-05-07 | -$1.90M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$707.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$851.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.47M derived: sum of 3 quarters · filed 2026-08-03 | -$1.83M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$767.00K derived: sum of 2 quarters · filed 2026-08-03 | -$1.13M 10-Q · filed 2025-11-06 | -$1.13M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$623.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$984.00K 10-Q · filed 2026-08-03 | -$984.00K derived: sum of 3 quarters · filed 2026-08-03 | |
| 2025-03-31 | -$361.00K 10-Q · filed 2026-05-07 | -$361.00K derived: sum of 2 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $74.00K 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $74.00K 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | -$1.53M 10-K · filed 2026-02-26 |